Company news

Intelligent Bio Solutions Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Intelligent Bio Solutions Receives NATA Accreditation for its Revolutionary Fingerprint Sweat Drug Screening System

December 18, 2023

Intelligent Bio Solutions Inc. Reports Fiscal 2024 First Quarter Financial Results and Operational Highlights

November 7, 2023

Intelligent Bio Solutions’ Innovative Drug Screening Technology Now Offered in New Zealand

October 23, 2023

Intelligent Bio Solutions Adds Logistics Firm to Fingerprint Drug Screening Portfolio and Completes Major Milestone with Existing Client

October 4, 2023

Intelligent Bio Solutions Inc. Announces Closing of $4.378 Million Underwritten Public Offering Including Partial Exercise of Underwriters’ Overallotment Option

October 3, 2023

Intelligent Bio Solutions Inc. Announces Pricing of $4,000,000 Underwritten Public Offering

October 1, 2023

Intelligent Bio Solutions Obtains ISO Recertification for its Intelligent Fingerprinting Drug Screening Business

September 26, 2023

Intelligent Bio Solutions Successfully Debuts Intelligent Fingerprinting Drug Screening Solution at the 2023 Workplace Health & Safety Show in Sydney, Australia

September 20, 2023

Intelligent Bio Solutions Completes Critical Development Milestone in Plans to Add Ketamine and Tramadol to Fingerprint Drug Test

September 7, 2023

Intelligent Bio Solutions Inc. Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results and Operational Highlights

August 23, 2023

Intelligent Bio Solutions Secures 8 New Customers with a Combined Workforce of Over 10,000 Employees Two Months into Product Launch in Australia

July 31, 2023

Intelligent Bio Solutions Signs South American Distribution Agreement with TSCOM for Fingerprint Drug Screening System and Secures First Order

July 5, 2023

Intelligent Bio Solutions Receives Guidance from U.S. FDA on a Regulatory Pathway for Expansion into the United States for its Intelligent Fingerprinting Drug Screening Cartridge

June 27, 2023

Intelligent Bio Solutions Receives Non-Dilutive Grant Funding of USD $1.43 Million

June 19, 2023

Intelligent Bio Solutions Inc. Reports Fiscal 2023 Third Quarter Financial Results and Operational Highlights

May 10, 2023

Intelligent Bio Solutions Secures UK Patent for Intelligent Fingerprinting DSR-Plus Cartridge Reader

April 17, 2023

Intelligent Bio Solutions Inc. Selects HASTA Laboratory as Drug Testing Specialist in Australia

March 12, 2023

Intelligent Bio Solutions Inc. Announces Closing of $2.55 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares and Warrants

March 9, 2023

Intelligent Bio Solutions Inc. Announces Pricing of $2.2 Million Public Offering

March 7, 2023

Intelligent Bio Solutions Inc. Announces Proposed Public Offering

March 6, 2023

Intelligent Bio Solutions Inc. Regains Compliance with Nasdaq Listing Requirement

February 28, 2023

Intelligent Bio Solutions Inc. files FDA 513(g) regulatory submission for Intelligent Fingerprinting Drug Screening Cartridge

February 15, 2023

Intelligent Bio Solutions Inc. Reports Fiscal 2023 Second Quarter Financial Results and Operational Highlights

February 13, 2023

Intelligent Bio Solutions Inc. Announces Leading Food Industry Logistics Provider to Implement Fingerprint Drug Testing, Replacing Urine Testing

February 6, 2023

Intelligent Bio Solutions Inc. Announces Global Garden Equipment Manufacturer to Introduce Intelligent Fingerprinting Drug Tests

January 30, 2023

Intelligent Bio Solutions Reaches Key Milestone in Biosensor Platform Development

January 22, 2023

Intelligent Bio Solutions Inc. Announces Closing of Private Placement Offering

December 21, 2022

Intelligent Bio Solutions Inc. Announces Cancellation of FY 2021 Annual Meeting of Stockholders

December 20, 2022

Intelligent Bio Solutions Inc. Reports First Quarter Ending September 30, 2022, Preliminary Financial Results and Recent Business Highlights

November 8, 2022

Intelligent Bio Solutions Inc. (INBS) Announces UK-Wide Glass Manufacturer to Roll Out Non-Invasive Drug Screening System Across UK Operations

November 6, 2022

Intelligent Bio Solutions Inc. Announces Airline Adopts Fingerprint Drug Screening System for In-house Testing

November 2, 2022

Intelligent Bio Solutions Inc. Announces Leading U.K. Container Haulier Switching to Fingerprint Drug Screening System for In-house Testing

October 30, 2022

GBS Inc. Announces Key Milestone in Prospective Study Comparing Glucose in Oral Fluids and Blood

July 12, 2022

GBS Inc. Announces Institutional Review Board Approval to Initiate Clinical Trial at Sutter Health Mills-Peninsula Medical Center

March 30, 2022

GBS, Inc. Announces Closing of Upsized $21.6 Million Initial Public Offering

December 27, 2020

← Newer news releases

Calls

Decks

The 5 newest of 8 decks. Every deck is listed under its year.